BOLLÉ-SAFETY
19.4.2021 10:32:04 CEST | Business Wire | Press release
Global eye protection specialist Bollé Safety now provides Trivex. A high-performance, high-technology prescription lens providing maximum security and great optical properties to ensure the best safety in a work environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210419005013/en/
The best of CR39 and polycarbonate in addition to unique features.
Bollé Safety’s latest lens material combines CR39’s lightness and polycarbonate’s durability. With a featherweight density (1,11g/cm3), Trivex is the lightest corrective lens material on the market. It also offers very good optical properties, superior to polycarbonate. The Trivex technology corrects some drawbacks traditionally attached to CR39 and polycarbonate. The lens is 20% thinner than CR39 and is shatterproof. Unlike polycarbonate, it is chemical and solvent resistant, making it safe to operate in a variety of work environments. Special new features include a 100% efficient UV filter that absorbs the totality of UVA and UVB for even better eye protection. And to ensure long-lasting aesthetics, the lens doesn’t turn yellow over time.
Why go to Bollé Safety to switch to Trivex?
Trivex properties are so high-performing that its technology was initially used for military purposes. With half of the global population over 20 years old suffering from vision problems, companies have a crucial interest in providing their workers with safety prescription eyewear that ensures optimal protection. Poor vision can lead to massive productivity losses and classic safety eyewear is not a one-size-fits-all product. Did you know that 90% of eye injuries could be prevented with proper protection and care? Wearing adapted and fitted eyewear can be a game-changer for professionals. Bollé Safety offers several ranges of products for plano and prescription lenses, so everyone can have perfect vision and safe working conditions. Bollé Safety’s latest frames, “KLASSEE” and “KURT”, make the most out of the Trivex technology. Thanks to Bollé’s unique global expertise, the KLASSEE model combines bio-sourced materials with side protections on the top and on the bottom of the frames. KURT is a great option with adjustable reinforced arms and an athletic frame for even more protection. The translucent front has been smoked to optimize side vision without being blinded. Lightweight and flexible, Bollé Safety glasses ensure a comfortable and secure experience and diminish risks in the work environment.
For more information, visit https://bit.ly/3e0A43j
About Bollé Safety.
Bollé Safety, the global brand for eye protection. Over our 130 years of existence, we have created more than 500 models of safety glasses. With a wide range of innovative, comfortable, and protective safety and prescription eyewear, we are trusted with the protection of over 20 million workers’ vision in 100 countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210419005013/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh
Spring is in Full Bloom at the Empire State Building with New Festive Experiences, Sweet Treats, and Seasonal Tower Lighting26.3.2026 21:30:00 CET | Press release
Spring is in full swing at the “World’s Most Famous Building.” The Empire State Building (ESB) today announced a vibrant lineup of spring events in NYC, which include special experiences, treat pop-ups, and an iconic tower lighting that captures the joy and color of the beautiful season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326216271/en/ Spring is in Full Bloom at the Empire State Building with New Festive Experiences, Sweet Treats, and Seasonal Tower Lighting “The Empire State Building Observation Deck has transformed into a celebration of the season and one of the best things to do in NYC this spring,” said Dan Rogoski, observatory general manager. “Whether it’s views beside our butterfly installation, sweet pop-ups, or a chance to spot the Easter Bunny, there is something special for every visitor.” Flutter of Color: The Empire State Building installed a brand-new photo opportunity on the 86th Floor Observati
Venture Global and Edison Announce Calcasieu Pass Arbitration Settlement26.3.2026 21:15:00 CET | Press release
Today, Venture Global and Edison jointly announced the signature of a commercial agreement for the settlement of the pending arbitration between the two companies concerning the Calcasieu Pass project. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326559130/en/ Completion of the settlement is expected by the end of Q2 2026, at which point the arbitration will be terminated. The agreement fully resolves the arbitration in its entirety. As part of the settlement, Edison and Venture Global have also agreed to the delivery to Europe of additional cargoes beyond those envisaged under the long-term contract, to support gas supplies primarily to the Italian market. The first delivery is scheduled for May 2026, in Italy, at the Adriatic LNG Terminal. The agreement represents a significant step in strengthening commercial cooperation between the parties and it establishes a foundation for further future deliveries in the context
Reply Recognized as a Microsoft Frontier Partner for Enterprise AI Delivery26.3.2026 19:06:00 CET | Press release
Reply [EXM, STAR: REY] announces it has been recognized as a Microsoft Frontier Partner within the Microsoft AI Cloud Partner Program, earning the Frontier Partner Badge for demonstrating advanced capabilities in delivering AI-first solutions across Cloud & AI Platforms, AI Business Solutions, and Security. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326965586/en/ The recognition reflects Reply’s capabilities across the Microsoft ecosystem, built through the work of its specialized companies – including Aim Reply, Business Elements Reply, Cluster Reply, Root16 Reply, Solidsoft Reply, Valorem Reply, WM Reply and Zest Reply – supporting enterprise organizations in designing, implementing, and operating AI solutions on Microsoft platforms across real-world business scenarios. The Frontier Partner badge recognizes partners that demonstrate advanced AI driven capabilities and meet rigorous badge requirements at the time of
SLB Announces Dates for First-Quarter 2026 Results Conference Call26.3.2026 18:00:00 CET | Press release
SLB (NYSE:SLB) will hold a conference call on April 24, 2026, to discuss the results for the first quarter ending March 31, 2026. The conference call is scheduled to begin at 11:00 a.m. US Eastern time and a press release regarding the results will be issued at 7:00 a.m. US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (833) 470-1428 within North America or +1 (404) 975-4839 outside of North America approximately 10 minutes prior to the start of the call and the access code is 742955. A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/972985185 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until May 1, 2026, and can be accessed by dialing +1 (866) 813-9403 within North America or +1 (929)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom